Notícias Alpha Tau Medical Ltd - DRTSW | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Alpha Tau Medical Ltd (DRTSW)
Alpha Tau Medical Ltd (DRTSW) Notícias

Alpha Tau Medical Ltd (DRTSW)

0,26

0,0475

(22,35%)

No fechamento: 27 Novembro 6:00PM

Atrasado por 15 minutos

0,26

0,00

( 0,00% )

Após o horário de negociação: 6:07PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau Treats First Patient with Recurrent Lung Cancer

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Con

Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Alpha Tau to Present at the Jefferies Global Healthcare Conference

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Alpha Tau Medical

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições